Ignite Creation Date:
2024-05-06 @ 1:46 AM
Last Modification Date:
2024-10-26 @ 11:09 AM
Study NCT ID:
NCT01891565
Status:
UNKNOWN
Last Update Posted:
2013-07-03
First Post:
2013-06-26
Brief Title:
Stroke Inpatients Rehabilitation Reinforcement of Activity
Sponsor:
University of Ibadan
Organization:
University of Ibadan
Study Overview
Official Title:
Stroke Inpatients Rehabilitation With Accelerometer-based Feedback Reinforcement of Activity
Status:
UNKNOWN
Status Verified Date:
2013-06
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The amount of active therapy provided to patients on an inpatient stroke rehabilitation unit has been reported as often insufficient Observational studies have found that in the first 14 days post stroke patients receive very little therapy and have very low activity levels More opportunity to practice may however improve short-term outcomes such as the level of mobility endurance use of the affected arm and leg and length of stay The Stroke Inpatient Rehabilitation Reinforcement of ACTivity SIRRACT trial will utilize sensors that reveal the type quantity and aspects of quality of patient activities outside of the confines of research laboratories SIRRACT will deploy inexpensive Personal Activity Monitors PAMs comprised of triaxial accelerometers worn on the thighs
The objectives of the study are
i To assess the impact of feedback from Personal Activity Monitors PAMs on amount of active practice walking speed and distance in stroke patients undergoing rehabilitation
ii To assess the impact of feedback from PAMs on physical psycho-emotional cognitive and ecosocial Health-Related Quality of Life of stroke patients undergoing rehabilitation
iii To assess the acceptability of thigh-strapped accelerometer use among stroke patients undergoing rehabilitation
iv To assess the reliability and validity of thigh-strapped accelerometer use among stroke patients undergoing rehabilitation
Hypotheses In moderate to severely disabled subjects who are receiving in-patient rehabilitation daily feedback from PAMs about purposeful activity will increase the amount of active practice by 30 a higher proportion of subjects who reach the level of independence for walking and increase walking speed by 25 leading to higher mean walking speeds and distances at the time of discharge from inpatient rehabilitation Daily feedback from PAMs on increase in walking speed and distances will improve physical psychological cognitive and ecosocial domains of Health-related quality of life
The objectives of the study are
i To assess the impact of feedback from Personal Activity Monitors PAMs on amount of active practice walking speed and distance in stroke patients undergoing rehabilitation
ii To assess the impact of feedback from PAMs on physical psycho-emotional cognitive and ecosocial Health-Related Quality of Life of stroke patients undergoing rehabilitation
iii To assess the acceptability of thigh-strapped accelerometer use among stroke patients undergoing rehabilitation
iv To assess the reliability and validity of thigh-strapped accelerometer use among stroke patients undergoing rehabilitation
Hypotheses In moderate to severely disabled subjects who are receiving in-patient rehabilitation daily feedback from PAMs about purposeful activity will increase the amount of active practice by 30 a higher proportion of subjects who reach the level of independence for walking and increase walking speed by 25 leading to higher mean walking speeds and distances at the time of discharge from inpatient rehabilitation Daily feedback from PAMs on increase in walking speed and distances will improve physical psychological cognitive and ecosocial domains of Health-related quality of life
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None